Building Blocks of Life & Amino Acid Metabolism and Disease

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/42

encourage image

There's no tags or description

Looks like no tags are added yet.

43 Terms

1
New cards

Inborn errors of metabolism

Genetic disorders caused by enzyme deficiencies in metabolic pathways.

2
New cards

Garrod’s hypothesis

Metabolic disease results from substrate buildup, product deficiency, and toxic intermediates.

3
New cards

Most metabolic disorders inheritance pattern

Autosomal recessive.

4
New cards

Phenylalanine hydroxylase (PAH)

Enzyme converting phenylalanine to tyrosine; deficient in PKU.

5
New cards

Cofactor required for PAH

Tetrahydrobiopterin (BH4).

6
New cards

Biochemical abnormality in PKU

High phenylalanine, low tyrosine, phenylketones in urine.

7
New cards

Phenylpyruvate

Toxic phenylalanine metabolite elevated in PKU.

8
New cards

Phenylacetate

PKU metabolite responsible for musty odor.

9
New cards

Phenyllactate

Alternate phenylalanine metabolite elevated in PKU.

10
New cards

Normal plasma phenylalanine

11
New cards

Classic PKU phenylalanine levels

20× normal.

12
New cards

Mild PKU phenylalanine levels

10–15× normal.

13
New cards

Non-PKU hyperphenylalaninemia

2–8× normal; often asymptomatic.

14
New cards

Age dependency of Phe toxicity

High Phe more harmful in young children due to brain development.

15
New cards

Major pathogenic mechanism of PKU

Phe outcompetes Tyr/Trp at LAT1 transporter → low neurotransmitters.

16
New cards

Neurotransmitters affected in PKU

Dopamine, norepinephrine, serotonin.

17
New cards

Why hypopigmentation occurs in PKU

Low tyrosine → low melanin synthesis.

18
New cards

Why tyrosine supplementation alone fails

Transporter competition prevents Tyr from entering brain.

19
New cards

Alternate phenylalanine pathways in PKU

Phenylalanine → phenylpyruvate → phenyllactate/phenylacetate.

20
New cards

Clinical symptoms of PKU

Intellectual disability, seizures, tremors, behavioral issues, hypopigmentation.

21
New cards

Newborn screening test for PKU

Guthrie bacterial inhibition assay.

22
New cards

Criteria for newborn screening

Cheap, stable metabolite, small blood volume, treatable disease.

23
New cards

Aspartame relevance to PKU

Contains phenylalanine; must be avoided.

24
New cards

BH4 therapy (Kuvan)

Effective only in mild PKU with residual PAH activity.

25
New cards

PAL enzyme therapy

Phenylalanine ammonia lyase converts Phe → trans-cinnamate.

26
New cards

Pegvaliase (Palynziq)

Pegylated PAL enzyme; reduces immunogenicity; lowers Phe.

27
New cards

Engineered microbiome therapy (SYNB1618)

E. coli Nissle engineered to degrade phenylalanine → hippurate.

28
New cards

Urea cycle disorders

Cause hyperammonemia; elevated arginine/citrulline.

29
New cards

Amino acids elevated in MSUD

Leucine, isoleucine, valine.

30
New cards

Odor of PKU

Musty or mousy.

31
New cards

Odor of MSUD

Maple syrup.

32
New cards

Odor of trimethylaminuria

Rotten fish.

33
New cards

Central role of glutamate in nitrogen metabolism

Primary amino group donor for transamination.

34
New cards

Central role of aspartate in nitrogen metabolism

Provides nitrogen for urea cycle.

35
New cards

Aromatic amino acid hydroxylases

Require BH4 cofactor.

36
New cards

Aromatic amino acid decarboxylase

Requires PLP (vitamin B6).

37
New cards

Phenylalanine transport issue in PKU

Phe saturates LAT1 transporter at BBB → blocks Tyr/Trp entry.

38
New cards

Defective brain myelination in PKU

Chronic and irreversible due to low protein synthesis.

39
New cards

Dietary treatment for PKU

Strict lifelong low-Phe diet + Phe-free amino acid formula.

40
New cards

Synthetic Phe-free formula issues

Bad taste, nutrient deficiencies, emotional stress, high cost.

41
New cards

Why PKU must be treated early

Prevent irreversible cognitive impairment.

42
New cards

PAH mutation types

Null, Vmax reduction, kinetic defects, unstable protein.

43
New cards

Genotype–phenotype correlation in PKU

Strong at enzyme level; weaker at cognitive level due to modifiers.